Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Opus Genetics (IRD) Long-Term Debt Issuances (2020)

Opus Genetics (IRD) reported Long-Term Debt Issuances of $449000.0 for Q4 2020, down 54.04% on a QoQ basis from $977000.0 in Q3 2020.

Opus Genetics (IRD) has 1 years of Long-Term Debt Issuances data on file, last reported at $449000.0 in Q4 2020.

  • Quarterly Long-Term Debt Issuances changed N/A year-over-year to $449000.0 in Q4 2020, while the trailing twelve-month figure through Sep 2021 was $449000.0 (down 74.31% YoY) and the FY2025 annual result came in at $1.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances declined to $449000.0 in Q4 2020 per IRD's latest filing, from $977000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $977000.0 in Q3 2020 and bottomed at $323000.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.73 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Opus Genetics 357.99 Mn 298.03 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 449,000.00
Dec 31, 2020 449,000.00
Sep 30, 2020 977,000.00
Sep 30, 2020 977,000.00
Jun 30, 2020 323,000.00
Jun 30, 2020 323,000.00
Mar 31, 2020 448,000.00
Mar 31, 2020 448,000.00